Bruno Pouzet

I founded and developed a business specialized in the importation and sales of French delicacies from small producers, which I turned into a profitable venture. I achieved a 116% increase in profitability through three recent strategic adjustments—product selection, pricing, and sales channels. This obtained during a period of high inflation. I managed the entire supply chain, marketing, sales, logistics, and ensured strict compliance with Danish regulations specific to food and alcoholic beverages. Now that this business is on the safe way, I can work further on freelance consulting in the drug discovery domain.

I developp preclinical strategies for R&D organizations across various projects in psychiatry, degenerative diseases, and inflammation. For these projects, I provided preclinical strategies, selected CROs from my database, and supervised of outsourced studies. My clients included academic researchers, start-ups, and international pharmaceutical companies.

More specifically, tasks supported from my agency included:

Some examples of concrete projects performed for clients:

At Hoffmann-La Roche, as a Group Leader, I led and reorganized a team of four PhD scientists and 15 technicians in Basel, as well as a smaller team in California. Together with selected external partners (CROs and academics), I built and maintained a highly efficient team to support numerous internal projects.

I designed and oversaw the implementation of in-vivo workflows that enabled approximately 10 transitions of "clinical lead series" or "entry into GLP tox" within the CNS pipeline over three years. My teams and I also developed translational models for late-stage compounds, resulting in three entries into human studies (EIH) over two years. My work involved preclinical efficacy and toxicology studies across various animal species, from rodents to mini-pigs.

As project leader, I recovered a project in the domain of cognitive dysfunction, by reorganizing the working group and defining achievable goals in line with time-lines given by the scientific executive management. It included the writing of monographs, and chapters for investigator brochures.

In collaboration with the IT department we developed an electronic lab-book system to move from paper books to an electronic GLP approved system.